Causes of Thyroid Lesions
Thyroid lesions are predominantly benign (95%) and arise from either non-neoplastic processes (multinodular goiter, diffuse goiter, thyroiditis) or neoplastic processes (benign adenomas and malignant carcinomas), with only approximately 5% being malignant. 1
Primary Etiologic Categories
Non-Neoplastic Lesions (Most Common)
Non-neoplastic conditions represent the majority of thyroid pathology, accounting for approximately 45-77% of thyroid lesions depending on the population studied 2, 3:
- Nodular hyperplasia/Multinodular goiter (24.9-45.0% of cases) - the single most common thyroid lesion 2, 3
- Diffuse goiter (31.5% of cases) 2
- Chronic lymphocytic (Hashimoto's) thyroiditis - autoimmune destruction leading to hypothyroidism 4, 5
- Subacute (de Quervain's) thyroiditis - inflammatory condition 4
- Graves' disease - autoimmune hyperthyroidism 4, 5
The underlying pathophysiology differs: iodine deficiency remains a major driver in endemic regions (particularly Africa), while autoimmune mechanisms predominate in iodine-sufficient areas 2, 5.
Neoplastic Lesions
Neoplasms comprise 18.9-55.1% of thyroid lesions, with significant variation based on patient selection 2, 3:
Benign neoplasms:
- Follicular adenoma (20.0% of all lesions) - the most common benign thyroid tumor 3
- Oncocytic (Hürthle cell) adenoma 6
Malignant neoplasms (5% average, range 1.5-38.1%): 1
- Papillary thyroid carcinoma (7.2-24.9% of all lesions) - represents >50% of all thyroid cancers in developed countries 1, 2, 3
- Follicular carcinoma (4.5% of lesions) 2
- Medullary thyroid carcinoma 7
- Anaplastic carcinoma 4
Risk Factors and Epidemiologic Patterns
Key demographic and exposure factors:
- Female predominance: 5.5:1 to 6:1 female-to-male ratio across all thyroid lesions 2, 5
- Age: Peak incidence in 4th-6th decades; nodule prevalence increases progressively with age 2, 8
- Iodine deficiency: Major cause in endemic regions, particularly Africa 2
- Radiation exposure: Increases nodule incidence and malignancy risk 8
- Autoimmune predisposition: Drives Hashimoto's thyroiditis and Graves' disease, more common in women 4, 5
Critical Clinical Context
The 2022 French consensus guidelines emphasize that the vast majority of thyroid nodules are benign, and there is no evidence that benign nodules undergo malignant transformation 1. The dramatic increase in thyroid cancer diagnoses over recent decades reflects overdetection of papillary microcarcinomas through improved imaging rather than true disease increase, as mortality has remained stable 1.
Detection Method Influences Apparent Prevalence
The reported frequency varies dramatically by detection method 8:
- Palpation: 2-6% prevalence
- Ultrasound: 19-35% prevalence
- Autopsy studies: 8-65% prevalence
This explains why incidental thyroid nodules are increasingly discovered with widespread imaging use in clinical practice 8.
Important Caveats
Do not biopsy nodules <10mm unless high-risk features are present (suspicious ultrasound characteristics, pathologic lymph nodes, extrathyroidal spread, or high-risk patient history), as this leads to overdiagnosis and unnecessary treatment morbidity 7. The clinical goal is identifying only those cancers with high recurrence risk or mortality potential, not detecting every microscopic cancer 1.